跳至主要内容
临床试验/TCTR20200313001
TCTR20200313001尚未招募未知

ew tumor marker for early detection of hepatocellular carcinoma (HCC)

one0 个研究点目标入组 1,080 人开始时间: 2020年3月13日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
one
入组人数
1,080

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • 1. Patients aged 18 years and older
  • 2. The annual health check-up who has regular blood tests including high frequency sound tests and no lumps suspected of primary liver cancer
  • 3. Chronic hepatitis B patients Males aged over 40 years and females aged over 50 or have direct relatives with primary liver cancer
  • 4.Chronic hepatitis C patients with pathological effects of liver tissue With at least level 3 fascia Or the flexibility of the liver with transient elastography greater than or equal to 9.5 or blood Fibrotest® is greater than 0.58 regardless of whether it has been treated or not.
  • 5. Patients who have been diagnosed with liver cirrhosis for any reason From the examination of high frequency sound waves Radiographic images using a computer or an X-ray of the upper abdomen.
  • 6. Patients who have detected a lump in the liver greater than or equal to 1 cm in size from the ultrasound Radiographic images using a computer or an X-ray of the upper abdomen.

排除标准

  • 1. pregnant patients
  • 2. Patients with jaundice from biliary tract obstruction
  • 3. Patients who received vitamin K during the study
  • 4. Patients receiving warfarin While studying
  • 5. Other types of cancer detected While diagnosing primary liver cancer

研究者

发起方
one

相似试验